Research Center Profile:
CNS Research of CT, Inc.
CNS Research inc. is a multi-site PPPN, (Private Practice
Physician's Network). Our goal is to provide the best possible
patient care by offering sophisticated and diverse pharmacological
research opportunities with medications not available to the
general public. Working with pharmaceutical companies, we provide
cutting edge evaluations, treatment and education of central
nervous systems disorders.
We focus on phases II & III clinical trials. Therapeutic
areas are Alzheimer's Disease, Epilepsy, Migraine Headaches,
Multiple Sclerosis Diabetic Neuropathic Pain and Stroke. Our
investigators have successfully been conducting studies with the
following pharmaceutical companies:
|
Alzheimer’s Disease
| Sponsor |
Drug Name |
Phase |
Protocol |
Enrollment Commitment |
Completed Patients |
| Eli Lilly |
Olanzepine |
II |
FID-US-HGIC-008 |
10 |
8 |
| Janssen |
Galantamine |
III |
GAl-USA 10-18 |
63 |
55 |
| Neurochem |
Alzhemed |
III |
CL – 758007 |
12 |
23 |
| Novartis |
Exelon |
IIII |
CENA713BUS13 |
8 |
11 |
| ONO |
N/A/ |
II |
ONO-2506 |
8 |
8 |
| BAYER |
METRIFONATE |
IIII |
N/A |
8 |
6 |
| PARKE-DAVIS |
MILAMELINE |
III |
N/A |
12 |
10 |
| HOECHST |
MENTANE |
III |
N/A |
10 |
8 |
Migraine Headaches
| Sponsor |
Drug Name |
Phase |
Protocol |
Enrollment Commitment |
Completed Patients |
| J&J PRI |
Topamax |
III |
MIG-002 |
08 |
15 |
| AstraZeneca |
Zomig |
III |
311CUS/0022 |
10 |
12 |
| GSK |
Sumatriptan |
III |
SUM40299 |
08 |
09 |
| ZICAM |
MTX-M3 |
III |
MTX-M3 |
10 |
10 |
Epilepsy
| Sponsor |
Drug Name |
Phase |
Protocol |
Enrollment Commitment |
Completed Patients |
| J&J PRI |
Topamax |
III |
EPMN-106 |
10 |
06 |
| Élan |
Zonegran |
III |
AN46046-304 |
06 |
09 |
| GSK |
Lamictal |
III |
LAM40124 |
06 |
03 |
Multiple Sclerosis
| Sponsor |
Drug Name |
Phase |
Protocol |
Enrollment Commitment |
Completed Patients |
| Teva |
Copaxone |
II |
Copolymer |
10 |
6 |
| Peptimmune |
Cytokine |
II |
MS-001 |
20 |
24 |
Diabetic Neuropathic Pain
| Sponsor |
Drug Name |
Phase |
Protocol |
Enrollment Commitment |
Completed Patients |
| J&J PRD |
Topamax |
III |
NP-001 |
10 |
07 |
| SANKYO |
Fidaristat |
II |
SNK-860-201 |
06 |
03 |
Stroke
| Sponsor |
Drug Name |
Phase |
Protocol |
Enrollment Commitment |
Completed Patients |
| Park-Davis |
Fosphenytoin |
II |
N/A |
10 |
08 |
| ONO |
ONO-2506 |
II |
ONO-2506 |
08 |
06 |
| BMS |
|
II |
N/A |
10 |
07 |
| Yamanuchi |
YM 872 |
II |
YM 872 |
06 |
04 |
Lower Back Pain
| Sponsor |
Drug Name |
Phase |
Protocol |
Enrollment Commitment |
Completed Patients |
| Praecis |
Latranal |
III |
2145-00-03 |
12 |
11 | |
We have a network of independent, private practice neurology,
psychiatry and pain centers located in Rhode Island, Massachusetts
and Connecticut . Through this network, CNS Research has
established in-depth knowledge of the independent sites, patient
access, capabilities, staffing, experience, etc. Through an
established communication infrastructure based on a virtual private
network, we have electronic databases that carry detailed
information as to the sites’ current profile, including current
electronic CVs for each physician and each coordinator. We have a
track record with each site across all CNS, psychiatric and pain
disease areas. We have historical knowledge as to patient
recruitment techniques that are appropriate and successful in the
local community in which the site is located. All this information
results in CNS Research’s ability to start studies quicker and
complete studies as scheduled or ahead of our competition.
Our Private Practice Physician's network is comprised of
seven leading neurologists:
- Dr. Norman M. Gordon
Medical Director and Vise President of CNS Research, Inc.
Dr. Norman Gordon received his medical degree from the University
of the Witwatersrand in Johannesburg, South Africa. He completed an
Internal Medicine Residency at the Miriam Hospital in Providence,
Rhode Island. Dr. Gordon completed a Neurology Residency at the RIH
Department of Neurology, serving as Chief Resident from 1987-1988.
Dr. Gordon is certified by the American Board of Psychiatry and
Neurology and the American Board of Internal Medicine. He is a
member of the American Academy of Neurology, the Rhode Island
Medical Society, and the American Association for the Study of
Headache.
RESUME
LICENSE VERIFICATION
- Dr. Dennis Aumentado
Dr. Dennis Aumentado received his undergraduate degree in Biology
in 1979 by the University of Cincinnati. He received his medical
degree in 1984 from the University of the East in Manila,
Philippines. He served his internship and residency in internal
medicine at Write State University in Dayton, Ohio and his
residence in Neurology at the University of Pittsburgh, where he
also received a Fellowship in Epilepsy.
RESUME
LICENSE VERIFICATION
- Dr. Peter Bellafiore
Dr. Peter J. Bellafiore offers diagnosis and treatment of general
neurological conditions and disorders. Dr. Bellafiore is a
physician who is highly trained to treat disorders of the nervous
system, which include diseases of the brain, spinal cord, nerves,
and muscles. Some of the more common conditions that a neurologist
diagnoses and treats are as follows: Strokes Epilepsy (seizures)
Headaches, Dementias (Alzheimer's disease), Multiple sclerosis,
Parkinson's disease, Various forms of pain Dr. Bellafiore has
expertise in the latest neurological technology and innovations. He
emphasizes patient education and encourages patients to share in
decision making.
RESUME
LICENSE VERIFICATION
- Dr. Vladislav Zayas
Dr. Vladislav Zayas received his Medical Doctorate from Brown
University in 1989. He pursued a Medical Internship at the Miriam
Hospital in Providence, Rhode Island. Dr. Zayas completed his
Neurological Residency at the RIH Department of Neurology, also in
Providence.
Area of Expertise: Alzheimer's
Disease, Migraine Headaches, Multiple Sclerosis.
RESUME
LICENSE VERIFICATION
- Dr. Fred Griffith, MD
Dr. Fred Griffith received his Medical Doctorate from the
University of Rochester School of Medicine and Dentistry in 1978.
He completed his residency at the New England Medical Center in
Boston.
Area of Expertise: Internal Medicine,
Neurology
RESUME
LICENSE VERIFICATION
- Patricia Epple, RN, BS, CCRC
Research Director
Patricia J. Epple earned her Certification as a Clinical Research
Coordinator as the site manager of the Department of Neurology at
the Miriam Hospital. With her twenty years experience in the
healthcare industry, she has been managing clinical research trials
for over 15 years. Her responsibilities include acquisition of new
clinical trials, budget negotiations, promotion and supervision of
ongoing projects. Patricia is currently the Director of the Stroke
Team at Miriam Hospital, responsible for enrolling patients under
emergency conditions.
RESUME
LICENSE
Our affiliation with Southeastern New England's largest
Academic Medical Centers allows us to draw patients from Rhode
Island, Eastern Massachusetts, and Connecticut. Community based
services such as "Memory and Cognitive Disorders Assessment
Service" offer the most comprehensive clinic in the region for
evaluation of memory loss.
Patricia T. Schumacher, RN, CRC
Study Coordinator
CNS Research of CT, Inc.
P.O. Box 2047
Pawcatuck, CT 06379
USA
Phone: 1-800-707-6013 Ext. 103
Fax: 1-800-847-4332
EMail: info@cns-research.com
Web Site: http://www.cns-research.com
The following trial(s) are actively recruiting patients:
If you are interested in contacting this center to discuss placing a clinical
trial there, please complete and send the E-mail form below. A representative from
the research center will then follow up with you.